12:00 AM
Jun 09, 2014
 |  BC Week In Review  |  Company News  |  Deals

Assembly Pharmaceuticals Inc., Ventrus Biosciences Inc. deal

The companies will merge in a stock deal. Assembly shareholders will receive 20.3 million Ventrus shares valued at $23.2 million based on Ventrus' close of $1.06 on May 16, the last trading day before...

Read the full 150 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >